Mice
, Andrea Szalai a To validate the potential anti-inflammatory and analgesic role of sita-and vildagliptin, five different experimental 23 models were used in mice: i) mustard oil-induced ear edema, ii) neutrophil accumulation, iii) mechanical and iv) 24 thermal touch sensitivity in complete Freund's adjuvant-induced arthritis and v) capsaicin-induced plasma 25 extravasation in the urinary bladder. For the complete examination period in i) the dose of 10 mg sitagliptin as 26 well as 1-10 mg vildagliptin was found to significantly decrease ear edema as compared to positive control 27 (p b 0.05, n = 8/group). All doses of sitagliptin provided an anti-inflammatory effect p b 0.005 (n = 10/ 28 group) in test ii) and an analgesic effect in iii) except 3 mg. Vildagliptin was similarly effective in test ii) 29 (p b 0.005, n = 10/group) as sitagliptin, but it failed to affect mechanical touch sensitivity. Unlike mechanical 30 touch sensitivity, both gliptins could beneficially act on the thermal threshold (p b 0.05, n = 10/group). And 31 only in tests v) could both gliptins reverse inflammation. Further studies are needed to support the suggestion 32 that the utilization of these beneficial effects of gliptins may be considered in the treatment of Type 2 diabetic 33 patients. 34 © 2014 Published by Elsevier B.V. 
before the commencement of ear edema induction. Since baseline values of diverse groups were significantly different in 274 all measurements, a baseline correction was carried out on raw values.
275
Baseline corrected values were regarded as primary outcome measures.
276
Two-way ANOVA with replication was used for multiple group analysis 277 with the time point of observation and the treatment option as factors The effect of vildagliptin treatment was similar to that of sitagliptin, 300 although the dose of 3 mg/kg had only an insignificant impact. and vildagliptin (both 1 mg and 3 mg p b 0.001) significantly (Fig. 4) .
305
Difference in action was seen between the higher doses (3 mg/kg) of Results show that the mechano-nociceptive threshold of the un-310 treated group was significantly higher than in the CFA treated (positive 
control) group during the whole 21 day experimental period (Fig. 3) . In 312 the gliptin treated groups every threshold was significantly lower 313 than in the negative control group; consequently neither sita-, nor 314 vildagliptin treatment was able to hinder the evolution of allodynia. in a dose-dependent manner however, sitagliptin had a higher impact.
359
This effect cannot be explained by the regulatory role of GLP-1 on p38
360
MAPK, as it was described as an inducer [36] ; neither can it be attributed 361 to the effect of gliptins on substance P metabolism [37] . Moreover, the Gliptins were administered by oral gavage in 1 or 3 mg/kg dose 30 minutes before the capsaicin (1 mg/kg) intravenous challange. Evans blue dye was administered in 30 mg/kg i.v. and the plasmaextravasation was determined spectrophotometrically at 620 nm wave length. Error bars denote standard error of the mean. * and × denote significant differences to negative control and to vildagliptin 1 mg, respectively as assessed by Games-Howell post hoc test. 
